PRENW
Prenetics Global LimitedConsumer Defensive · $257M market cap
Is PRENW undervalued?
Share price
$0.009
as of Oct 29, 2026
Fair value
$26.64
Sticker Price
Payback Price
—
no buy price
Based on annual results to Dec 2025.
PRENW is down 36% since these results were published. The fair value doesn't include anything reported since.
UndervaluedPRENW is Undervalued: at $0.009 it trades 100% below its fair value of $26.64. There's no buy price: it has lost money 3 years in a row, so its value rests on sales alone. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.
How we valued it
Sales-Based (P/S). It has reported a loss for 3 years in a row and doesn't produce cash consistently yet (0 of the last 3 years), so we value it on its sales.
Business quality
2 of 5 clear the 10% bar. What are the Big Five?
Follow PRENW
Track it on your watchlist and see the full analysis. Free.
Create a free accountQuestions about PRENW
What is PRENW's fair value?
$26.64 as of Oct 29, 2026, worked out with the Sales-Based (P/S). It has reported a loss for 3 years in a row and doesn't produce cash consistently yet (0 of the last 3 years), so we value it on its sales.
At what price would PRENW be a buy?
We don't publish a buy price for PRENW: it made a loss in each of the last three years, so its fair value comes from its sales and is too uncertain to buy against.
Is PRENW undervalued right now?
PRENW is Undervalued: at $0.01 it trades 100% below its fair value.
How can I check PRENW's value myself?
Use the free Sticker Price calculator, already filled with PRENW's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →
Similar stocks · Household & Personal Products
About Prenetics Global Limited
Prenetics Global Limited operates as an investment holding company specializing in diagnostics and genetic testing. Its core offerings include CircleDNA, a consumer genetic testing solution, and the Circle HealthPod, a rapid detection health monitoring system that enables users to perform point-of-care or at-home COVID-19 tests using nucleic acid amplification technology. The company's portfolio further comprises ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an accessible at-home blood testing kit; and Circle Medical, a diagnostic testing platform. Other products include Circle One, F1x, and Fem. Established in 2014, Prenetics Global Limited is headquartered in Quarry Bay, Hong Kong.
Household & Personal Products
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Oct 29, 2026. How the Payback Price works